Coherus BioSciences, Inc. (CHRS) Financial Statements (2024 and earlier)

Company Profile

Business Address C/O DENNIS M. LANFEAR
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:191,681417,195541,200177,66872,356126,911
Cash and cash equivalents63,547417,195541,158177,66872,356126,911
Short-term investments128,134     
Other undisclosed cash, cash equivalents, and short-term investments   42   
Restricted cash and investments     5060
Receivables109,964123,022157,046141,992 908
Inventory, net of allowances, customer advances and progress billings38,79137,64244,2339,8071,659 
Inventory38,79137,64244,2339,8071,659 
Prepaid expense     2,37918,364
Other current assets     83142
Other undisclosed current assets40,79824,46425,00013,5427,906(908)
Total current assets:381,234602,323767,479343,00984,433145,477
Noncurrent Assets
Inventory, Noncurrent76,26055,61047,95645,2644,012 
Finance lease, right-of-use asset, after accumulated amortization   1,451 
Operating lease, right-of-use asset   9,95610,649
Property, plant and equipment8,7547,813 5,8406,66012,773
Intangible assets, net (including goodwill)5,9313,5633,5633,5633,5633,563
Goodwill 943943943943943
Intangible assets, net (excluding goodwill)5,9312,6202,6202,6202,6202,620
Restricted cash and investments   440240785785
Other noncurrent assets8,66810,0252,1473621413
Other undisclosed noncurrent assets   8,657   
Total noncurrent assets:99,61377,01174,17065,91815,03417,134
TOTAL ASSETS:480,847679,334841,649408,92799,467162,611
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities61,62386,30060,26361,65332,84224,531
Employee-related liabilities22,01422,24418,41010,540 
Accounts payable11,52616,15915,20125,98515,29415,481
Accrued liabilities50,09748,12722,81817,2587,0089,050
Debt 1,1917415602,196  
Estimated litigation liability 4,700     
Business combination, contingent consideration, liability      3,290
Other liabilities   3,8612,196419341
Other undisclosed current liabilities71,18078,28680,96948,924 233
Total current liabilities:138,694165,327145,653114,96933,26128,395
Noncurrent Liabilities
Long-term debt and lease obligation226,993388,411387,343162,46177,31976,206
Long-term debt, excluding current maturities225,575381,160377,395152,20577,31976,206
Finance lease, liability 1,418498875 
Liabilities, other than long-term debt7,09527,87027,67926,28327,47827,475
Due to related parties 27,12026,62826,18125,77325,402
Other liabilities3,467750949 1,6452,073
Operating lease, liability 3,6286,7539,07310,256
Business combination, contingent consideration, liability   10210260 
Other undisclosed noncurrent liabilities245,483     
Total noncurrent liabilities:479,571416,281415,022188,744104,797103,681
Total liabilities:618,265581,608560,675303,713138,058132,076
Equity
Equity, attributable to parent(137,418)97,726280,974105,214(38,591)31,824
Common stock877776
Additional paid in capital1,204,4311,147,8431,043,9911,000,763946,515808,060
Accumulated other comprehensive loss(249)(270)(270)(558)(282)(750)
Accumulated deficit(1,341,608)(1,049,854)(762,754)(894,998)(984,831)(775,492)
Equity, attributable to noncontrolling interest      (1,289)
Total equity:(137,418)97,726280,974105,214(38,591)30,535
TOTAL LIABILITIES AND EQUITY:480,847679,334841,649408,92799,467162,611

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues211,042326,551475,824356,071 1,556
Revenue, net1,556
Cost of revenue
(Cost of Goods and Services Sold)
(70,083)(57,591)(37,667)(410)  
Gross profit:140,959268,960438,157355,661 1,556
Operating expenses(397,839)(532,818)(281,838)(248,303)(204,416)(233,692)
Other undisclosed operating income    410  
Operating income (loss):(256,880)(263,858)156,319107,768(204,416)(232,136)
Nonoperating income (expense)3,822(283)8212,8474,6913,402
Investment income, nonoperating   600   
Gain (loss), foreign currency transaction, before tax   (333)239  
Other nonoperating income (expense)3,822(283)5542,6084,6913,402
Interest and debt expense(38,696)(22,959)(21,166)(17,601)(9,684)(9,552)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (267)(240)  
Income (loss) from continuing operations before equity method investments, income taxes:(291,754)(287,100)135,70792,774(209,409)(238,286)
Other undisclosed income from continuing operations before income taxes    1  
Income (loss) from continuing operations before income taxes:(291,754)(287,100)135,70792,775(209,409)(238,286)
Income tax expense (benefit)  (3,463)(2,942)  
Income (loss) from continuing operations:(291,754)(287,100)132,24489,833(209,409)(238,286)
Income (loss) before gain (loss) on sale of properties:(287,100)132,24489,833(209,409)(238,286)
Net income (loss):(291,754)(287,100)132,24489,833(209,409)(238,286)
Net income attributable to noncontrolling interest     70116
Net income (loss) available to common stockholders, diluted:(291,754)(287,100)132,24489,833(209,339)(238,170)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(291,754)(287,100)132,24489,833(209,409)(238,286)
Other comprehensive income (loss)21     
Other undisclosed comprehensive income (loss)  288(276)468(120)
Comprehensive income (loss):(291,733)(287,100)132,53289,557(208,941)(238,406)
Comprehensive income, net of tax, attributable to noncontrolling interest     70116
Comprehensive income (loss), net of tax, attributable to parent:(291,733)(287,100)132,53289,557(208,871)(238,290)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: